Literature DB >> 29809245

Precision Screening for Lung Cancer: Risk-Based but Not Always Preference-Sensitive?

Michael K Gould1.   

Abstract

Mesh：

Year:  2018        PMID： 29809245     DOI： 10.7326/M18-1350

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  3 in total

1.  Potential Impact of Cessation Interventions at the Point of Lung Cancer Screening on Lung Cancer and Overall Mortality in the United States.

Authors:  Pianpian Cao; Jihyoun Jeon; David T Levy; Jinani C Jayasekera; Christopher J Cadham; Jeanne S Mandelblatt; Kathryn L Taylor; Rafael Meza
Journal:  J Thorac Oncol       Date:  2020-03-08       Impact factor: 15.609

2.  Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study.

Authors:  Dejana Braithwaite; Shama D Karanth; Christopher G Slatore; Dongyu Zhang; Jiang Bian; Rafael Meza; Jihyoun Jeon; Martin Tammemagi; Mattthew Schabath; Meghann Wheeler; Yi Guo; Bruno Hochhegger; Frederic J Kaye; Gerard A Silvestri; Michael K Gould
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

3.  Cancer prevention, risk reduction, and control: opportunities for the next decade of health care delivery research.

Authors:  Denalee M O'Malley; Catherine M Alfano; Michelle Doose; Anita Y Kinney; Simon J Craddock Lee; Larissa Nekhlyudov; Paul Duberstein; Shawna V Hudson
Journal:  Transl Behav Med       Date:  2021-11-30       Impact factor: 3.046
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.